Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T
Department of Internal Medicine (III), Kanazawa University School of Medicine, Japan.
Am J Hematol. 1991 Dec;38(4):281-7. doi: 10.1002/ajh.2830380406.
We examined the changes in plasma levels of soluble thrombomodulin in 66 cases of disseminated intravascular coagulation (DIC), to investigate the damage to vascular endothelial cells and its relationship to multiple organ failure. A significant elevation of plasma levels of soluble thrombomodulin was observed in most cases of DIC, especially in patients with sepsis. However, no such significant elevation was observed in patients with acute promyelocytic leukemia. Plasma levels of both soluble thrombomodulin and active plasminogen activator inhibitor were higher in the cases of DIC with multiple organ failure than in those without multiple organ failure. The levels of soluble thrombomodulin were decreased with the clinical improvement in most cases of DIC but were further increased or remained at high levels in patients who showed no improvement of DIC. It was suggested that an increase in soluble thrombomodulin indicates the damage to the vascular endothelial cells in cases of DIC and that the damage to vascular endothelial cells plays some role in further progression of multiple organ failure.
我们检测了66例弥散性血管内凝血(DIC)患者血浆可溶性血栓调节蛋白水平的变化,以研究血管内皮细胞损伤及其与多器官功能衰竭的关系。在大多数DIC病例中,尤其是脓毒症患者,观察到血浆可溶性血栓调节蛋白水平显著升高。然而,急性早幼粒细胞白血病患者未观察到此类显著升高。伴有多器官功能衰竭的DIC患者血浆可溶性血栓调节蛋白和活性纤溶酶原激活物抑制剂水平均高于无多器官功能衰竭的患者。在大多数DIC病例中,可溶性血栓调节蛋白水平随临床改善而降低,但在DIC无改善的患者中进一步升高或维持在高水平。提示可溶性血栓调节蛋白升高表明DIC病例中血管内皮细胞受损,且血管内皮细胞损伤在多器官功能衰竭的进一步发展中起一定作用。